Light Mode
$0.0000 ↓ -8.3400 (-100.00%) Trading Down from the previous close of $8.3400
+1.56 (+23.01%) / 6M
Momentum, market sentiment, and recent alerts
HBIO reads poor: the 12-month move is +1965.4%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, China, United Kingdom, and Rest of the World. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.